Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID–19 and chronic kidney disease: an updated overview of reviews
Sara S. Jdiaa, Razan Mansour, Abdallah El Alayli, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 1, pp. 69-85
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Advances in Electrochemical Sensors for Detecting Analytes in Biofluids
Jimin Lee, Myung-Chul Kim, Ira Soltis, et al.
Advanced Sensor Research (2023) Vol. 2, Iss. 8
Open Access | Times Cited: 20
Disasters and kidney care: pitfalls and solutions
Mehmet Şükrü Sever, Valérie A. Luyckx, Marcello Tonelli, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 672-686
Closed Access | Times Cited: 20
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study
Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 3, pp. 195-208
Closed Access | Times Cited: 6
Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients
Maria Shoukat, Haseeb Khan, Moona Nazish, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2
Marta Colaneri, Marta Canuti, G Torrigiani, et al.
Infectious Diseases and Therapy (2025) Vol. 14, Iss. 2, pp. 447-461
Open Access
Impact of Prior Chronic Kidney Disease and Newly Detected eGFR Impairment at Admission on Outcomes and Prognosis of Hospitalized COVID-19 Patients – A Single-Center Cohort Study
Michał Kania, Michał Terlecki, Krzysztof Batko, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 593-602
Open Access
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19–20 and WHF COVID-19 CVD Studies
Juan Esteban Gómez‐Mesa, Juan Pablo Arango-Ibañez, Pablo Perel, et al.
Global Heart (2025) Vol. 20, Iss. 1
Open Access
Relevance of comorbidities for main outcomes during different periods of the COVID‐19 pandemic
José M. Quintana, Lander Rodríguez, Janire Portuondo, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney Disease
Yifang Tang, Tao Liu, Shibo Sun, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2861-2871
Open Access | Times Cited: 4
The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases
Franco Wing Tak Cheng, Min Fan, Carlos King Ho Wong, et al.
Kidney International (2022) Vol. 102, Iss. 4, pp. 922-925
Open Access | Times Cited: 20
National early warning score (NEWS) 2 predicts hospital mortality from COVID-19 patients
Eric Carlo Wibisono, Usman Hadi, Bramantono, et al.
Annals of Medicine and Surgery (2022) Vol. 76
Open Access | Times Cited: 19
Evaluation of the Approach towards Vaccination against COVID-19 among the Polish Population—In Relation to Sociodemographic Factors and Physical and Mental Health
Justyna Gołębiowska, Anna Zimny-Zając, Mateusz Dróżdż, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 700-700
Open Access | Times Cited: 10
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Comorbidities associated with the severity of COVID-19, and differences across ethnic groups: a UK Biobank cohort study
Rahul Patel, Jaspal S. Kooner, Weihua Zhang
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Nationwide in-hospital mortality and morbidity analysis of COVID-19 in advanced chronic kidney disease, dialysis and kidney transplant recipients
Mingyue He, Yichen Wang, Si Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Nagarjunachary Ragi, Kumar Sharma
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 421-438
Open Access | Times Cited: 3
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 563-563
Open Access | Times Cited: 17
Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness—A Narrative Review
Ioana Mădălina Zota, Cristian Stătescu, Radu Andy Sascău, et al.
Life (2022) Vol. 12, Iss. 6, pp. 781-781
Open Access | Times Cited: 16
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
Sammy Patyna, Timon Eckes, Benjamin Koch, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 585-585
Open Access | Times Cited: 15
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance
Gaetano Scaramuzzo, Francesco Nucera, Alessio Asmundo, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Humoral immunity trends in a hemodialysis cohort following SARS‐CoV‐2 mRNA booster: A cohort study
Eibhlin Goggins, Binu Sharma, Z. Jennie, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 2
Risk of kidney and liver diseases after COVID‐19 infection: A systematic review and meta‐analysis
Bei Pan, Xiaoman Wang, Honghao Lai, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 2
Coronavirus Disease 2019
Charlotte P. Wills, Berenice Pérez, Justin X. Moore
Emergency Medicine Clinics of North America (2024) Vol. 42, Iss. 2, pp. 415-442
Closed Access | Times Cited: 2
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study
Wing Ming Chu, Eric Yuk Fai Wan, Zoey Cho Ting Wong, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102620-102620
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top